Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs (Q39700283)

14 September 2017

title

Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs (English)

1 reference

14 September 2017

0 references

0 references

Dirk Heshe

1

1 reference

14 September 2017

Stephanie Hoogestraat

2

1 reference

14 September 2017

Christine Brauckmann

3

1 reference

14 September 2017

Uwe Karst

4

1 reference

14 September 2017

Joachim Boos

5

1 reference

14 September 2017

Claudia Lanvers-Kaminsky

6

1 reference

14 September 2017

publication date

26 May 2010

1 reference

Cancer Chemotherapy and Pharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

67

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

647-655

1 reference

Why do cancers have high aerobic glycolysis?

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

The pharmacology of dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Dichloroacetate induces apoptosis in endometrial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Dichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Cancer patients opt for unapproved drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Mitochondrial Membrane Potential in Living Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Role of dichloroacetate in the treatment of genetic mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Chronic treatment of mitochondrial disease patients with dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-010-1361-6

10.1007/S00280-010-1361-6

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference